Opko Health (OPK) Q3 2024 Earnings Call Transcript
OPK earnings call for the period ending September 30, 2024.…
1,565$
-0,95%
Echtzeit-Aktienkurs OPKO Health
Bid:
Ask:
Nachrichten zur OPKO Health Aktie
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
Entera and OPKO Health announce positive PK/PD results from their ongoing collaborative research focused on developing the first oral dual…
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Healths laboratory testing…
Opko Health (OPK) Q2 2024 Earnings Call Transcript
OPK earnings call for the period ending June 30, 2024.…
OPKO Health, Inc. (OPK) Q2 2024 Earnings Call Transcript
…
OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down
Despite OPKO Healths (OPK) strength in the Diagnostics segment, its overall second-quarter results reflect soft performances.…
Opko Health (OPK) Q1 2024 Earnings Call Transcript
OPK earnings call for the period ending March 31, 2024.…
OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript
…
ROSEN, NATIONAL TRIAL LAWYERS, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL
NEW YORK, April 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory…
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.…
Opko Health CEO Phillip Frost buys $444,300 in company stock By Investing.com
Opko Health CEO Phillip Frost buys $444,300 in company stock…
Earnings call: OPKO Health reports mixed Q4 results By Investing.com
Earnings call: OPKO Health reports mixed Q4 results…
2 Penny Stocks Insiders Are Buying
Stocks Analysis by MarketBeat.com (Thomas Hughes) covering: Opko Health Inc, Southland Holdings Inc. Read MarketBeat.com (Thomas Hughes)s latest article on…
Opko Health (OPK) Q4 2023 Earnings Call Transcript
OPK earnings call for the period ending December 31, 2023.…
OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript
…
Opko Health earnings beat by $0.01, revenue topped estimates By Investing.com
Opko Health earnings beat by $0.01, revenue topped estimates…
OPKO Health reports pricing of private offering of $200M convertible senior notes due 2029
…
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
Proceeds to be used for privately negotiated repurchases of common stock and outstanding 4.50% Convertible Senior Notes due 2025 Proceeds…
Opko Health (OPK) Q3 2023 Earnings Call Transcript
OPK earnings call for the period ending September 30, 2023.…
OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript
…
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
Despite OPKO Healths (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.…
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE®…
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on…
OPKO Health: FDA Approval To Save The Company
…
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a…
Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 175.804$
Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2023-08-17...…
Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 131.260$
Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2023-08-14...…
Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 1.194.998$
Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2023-08-07...…
OPKO Health (OPK) Q2 Earnings and Revenues Top Estimates
Despite OPKO Healths (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall second-quarter results reflect soft performances....…
Opko Health (OPK) Q2 2023 Earnings Call Transcript
OPK earnings call for the period ending June 30, 2023....…
Form 10-Q OPKO HEALTH, INC. For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
OPKO Health GAAP EPS of -$0.03 beats by $0.04, revenue of $265.4M beats by $63.43M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial…
Form 8-K OPKO HEALTH, INC. For: Jun 29
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Shares of Opko Health Jumped on Thursday
The FDA approved a growth therapy the company was collaborating on with Pfizer....…
Pfizer Says Its NGENLA Gets FDA Approval To Treat Pediatric Growth Hormone Deficiency
NEW YORK CITY (dpa-AFX) - Biopharmaceutical major Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced on Wednesday that the…
Pfizer, OPKO Health win FDA nod for dwarfism therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K OPKO HEALTH, INC. For: Jun 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Is OPKO Health (OPK) Down 17.2% Since Last Earnings Report?
OPKO Health (OPK) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Form 8-K OPKO HEALTH, INC. For: May 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Innovation Officer kauft Aktien von Opko Health im Wert von 840.899$
Nabel, Gary J. - Vorstand - Tag der Transaktion: 2023-05-05...…
OPKO Health (OPK) Q1 Earnings and Revenues Top Estimates
Despite OPKO Healths (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall first-quarter results reflect soft performances....…
Opko Health (OPK) Q1 2023 Earnings Call Transcript
OPK earnings call for the period ending March 31, 2023....…
OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of 71.43% and 26.76%, respectively, for the quarter ended March 2023. Do…
OPKO Health GAAP EPS of -$0.02 beats by $0.06, revenue of $237.6M beats by $44.25M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial…